Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Progress in chimerism analysis in childhood malignancies – the dilemma of biostatistical considerations and ethical implications

An Erratum to this article was published on 02 May 2002

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, Gadner H, Lion T . Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection Leukemia 1999 13: 2060–2069

    Article  CAS  Google Scholar 

  2. Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V, Hoecker P, Fischer G, Dieckmann K, Handgretinger R, Klingebiel T, Gadner H . Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment Leukemia 1999 13: 2070–2078

    Article  CAS  Google Scholar 

  3. Bader P, Beck J, Frey A, Schlegel PG, Hebart H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T . Serial and quantitative analysis of mixed haematopoietic chimerism by PCR in patients with acute leukaemia allows the prediction of relapse after allogeneic BMT Bone Marrow Transplant 1998 21: 487–495

    Article  CAS  Google Scholar 

  4. Thiede C, Bornhaeuser M, Oelschlaegel J, Brendel C, Leo R, Daxberger H, Mohr B, Florek M, Kroschinsky F, Geissler G, Naumann R, Ritter M, Prange-Krex G, Lion T, Neubauer A, Ehninger G . Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers Leukemia 2000 (in press)

  5. Lion T, Daxberger H, Dubovsky J, Filipcik P, Fritsch G, Peters C, Matthes-Martin S, Lawitschka A, Gadner H . Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation Leukemia 2000 (in press)

  6. Lion T, Muller-Berat N . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations (Debate-Round Table) Leukemia 1999 13: 2059

    Article  CAS  Google Scholar 

  7. Bader P, Hölle W, Klingebiel T, Handgretinger R, Niethammer D, Beck J . Quantitative assessment of mixed haematopoietic chimerism by PCR after allogeneic bone marrow transplantation Anticancer Res 1996 16: 1759–1764

    CAS  PubMed  Google Scholar 

  8. Bader P, Hölle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG, Niethammer D, Beck J . Mixed haematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children Bone Marrow Transplant 1997 19: 697–702

    Article  CAS  Google Scholar 

  9. Bader P, Beck J, Schlegel PG, Handgretinger R, Niethammer D, Klingebiel T . Additional immunotherapy on the basis of increasing mixed haematopoietic chimerism after allogeneic BMT in children with acute leukaemia: is there an option to prevent relapse? Bone Marrow Transplant 1997 20: 79–81

    Article  CAS  Google Scholar 

  10. Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, Niethammer D, Beck JF . Prevention of relapse in paediatric patients with acute leukaemia's and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children Leukemia 1999 13: 2079–2086

    Article  CAS  Google Scholar 

  11. Sacks H, Chalmers TC, Smith H . Randomized versus historical controls for clinical trials Am J Med 1982 72: 233–240

    Article  CAS  Google Scholar 

  12. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermüller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050

    CAS  PubMed  Google Scholar 

  13. Armitage P, Berry G . The size of a statistical investigation. In: Armitage P, Berry G (eds) Statistical Methods in Medical Research, 3rd edn Blackwell Science: London 1998 pp 195–206

    Google Scholar 

  14. Lilford RJ, Thornton JG, Braunholtz D . Clinical trials and rare disease: a way out of a conundrum British Med J 1995 311: 1621–1625

    Article  CAS  Google Scholar 

  15. Siep L, Ethische Aspekte der Forschung mit nicht-einwilligungsfähigen Personen . In: Honnefelder L, Streffer C (eds). Jahrbuch für Wissenschaft und Ethik, Band 4 Walter de Gruyter: Berlin, New York 1999; pp 115–125

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klingebiel, T., Niethammer, D., Dietz, K. et al. Progress in chimerism analysis in childhood malignancies – the dilemma of biostatistical considerations and ethical implications. Leukemia 15, 1989–1991 (2001). https://doi.org/10.1038/sj.leu.2402315

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402315

This article is cited by

Search

Quick links